Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Baranova (St.Petersburg, Russian Federation), M. Ilkovich (St.Petersburg, Russian Federation), A. Speranskaya (St.Petersburg, Russian Federation). Variants of the clinical course of familial pulmonary sarcoidosis. 1395

Member's Comments

No comment yet.

Related content which might interest you: Variants of atypical course of sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Clinical and radiological variants of fibrosis pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Renal failure as first manifestation of familial sarcoidosis Source: Eur Respir J 2010; 36: 1485-1487 Year: 2010 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Gene variants and clinical course of pulmonary sarcoidosis in a Slavic population Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients. Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis Source: Eur Respir J, 49 (5) 1602314; 10.1183/13993003.02314-2016 Year: 2017 The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005 Novel rare genetic variants in idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020 Year: 2020 Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004 Problems of diagnosis of pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis Source: Eur Respir J 2010; 35: 324-330 Year: 2010 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007